201 related articles for article (PubMed ID: 32853731)
1. Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy.
Wang S; Wang R; Meng N; Guo H; Wu S; Wang X; Li J; Wang H; Jiang K; Xie C; Liu Y; Wang H; Lu W
J Control Release; 2020 Dec; 328():78-86. PubMed ID: 32853731
[TBL] [Abstract][Full Text] [Related]
2. Platelet Membrane-Coated r-SAK Improves Thrombolytic Efficacy by Targeting Thrombus.
Hua R; Li M; Lin Q; Dong M; Gong X; Lin Z; Li Y; Li C; Wu T; Tan C; Zhang W; Wang Q; Wu T; Zhou X; Yang F; Li C
ACS Appl Mater Interfaces; 2024 May; 16(17):21438-21449. PubMed ID: 38626407
[TBL] [Abstract][Full Text] [Related]
3. Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models.
Xu J; Zhang Y; Xu J; Liu G; Di C; Zhao X; Li X; Li Y; Pang N; Yang C; Li Y; Li B; Lu Z; Wang M; Dai K; Yan R; Li S; Nie G
Adv Mater; 2020 Jan; 32(4):e1905145. PubMed ID: 31788896
[TBL] [Abstract][Full Text] [Related]
4. GOx-Powered Janus Platelet Nanomotors for Targeted Delivery of Thrombolytic Drugs in Treating Thrombotic Diseases.
Fang X; Ye H; Shi K; Wang K; Huang Y; Zhang X; Pan J
ACS Biomater Sci Eng; 2023 Jul; 9(7):4302-4310. PubMed ID: 37307138
[TBL] [Abstract][Full Text] [Related]
5. Engineered platelets-based drug delivery platform for targeted thrombolysis.
Wang S; Wang R; Meng N; Lu L; Wang J; Zhou J; Lu J; Xu Q; Xie C; Zhan C; Li Y; Yu Y; Lu W; Liu M
Acta Pharm Sin B; 2022 Apr; 12(4):2000-2013. PubMed ID: 35847517
[TBL] [Abstract][Full Text] [Related]
6. Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.
Liu B; Victorelli F; Yuan Y; Shen Y; Hong H; Hou G; Liang S; Li Z; Li X; Yin X; Ren F; Li Y
Small; 2023 Jan; 19(4):e2205260. PubMed ID: 36424174
[TBL] [Abstract][Full Text] [Related]
7. Functionalized polymeric hybrid micelles as an efficient nanotheranostic agent for thrombus imaging and thrombolysis.
Wang Y; Xu X; Zhao X; Yin Z
Acta Biomater; 2021 Mar; 122():278-290. PubMed ID: 33359293
[TBL] [Abstract][Full Text] [Related]
8. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.
Pawlowski CL; Li W; Sun M; Ravichandran K; Hickman D; Kos C; Kaur G; Sen Gupta A
Biomaterials; 2017 Jun; 128():94-108. PubMed ID: 28314136
[TBL] [Abstract][Full Text] [Related]
9. Annexin V-Conjugated Mixed Micelles as a Potential Drug Delivery System for Targeted Thrombolysis.
Pan Y; Ren X; Wang S; Li X; Luo X; Yin Z
Biomacromolecules; 2017 Mar; 18(3):865-876. PubMed ID: 28240872
[TBL] [Abstract][Full Text] [Related]
10. Elaborately Engineering a Self-Indicating Dual-Drug Nanoassembly for Site-Specific Photothermal-Potentiated Thrombus Penetration and Thrombolysis.
Zhao Z; Zhang X; Zhang H; Shan X; Bai M; Wang Z; Yang F; Zhang H; Kan Q; Sun B; Sun J; He Z; Luo C
Adv Sci (Weinh); 2022 Feb; 9(4):e2104264. PubMed ID: 34802198
[TBL] [Abstract][Full Text] [Related]
11. Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.
Bonnard T; Tennant Z; Niego B; Kanojia R; Alt K; Jagdale S; Law LS; Rigby S; Medcalf RL; Peter K; Hagemeyer CE
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159824
[TBL] [Abstract][Full Text] [Related]
12. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
Huang Y; Yu L; Ren J; Gu B; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
J Control Release; 2019 Apr; 300():1-12. PubMed ID: 30807804
[TBL] [Abstract][Full Text] [Related]
13. A Biomimicking and Multiarm Self-Indicating Nanoassembly for Site-Specific Photothermal-Potentiated Thrombolysis Assessed in Microfluidic and In Vivo Models.
Liu KT; Quiñones ED; Liu MH; Lin CW; Chen YT; Chiang CC; Wu KC; Fan YJ; Chuang EY; Yu J
Adv Healthc Mater; 2023 Sep; 12(24):e2300682. PubMed ID: 37289540
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
Chen HA; Ma YH; Hsu TY; Chen JP
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
[TBL] [Abstract][Full Text] [Related]
15. Targeted thrombolysis by using c-RGD-modified N,N,N-Trimethyl Chitosan nanoparticles loaded with lumbrokinase.
Liao J; Ren X; Yang B; Li H; Zhang Y; Yin Z
Drug Dev Ind Pharm; 2019 Jan; 45(1):88-95. PubMed ID: 30198790
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-Propelled Janus Rod-Shaped Micromotors for Site-Specific Sonodynamic Thrombolysis.
Cao W; Liu Y; Ran P; He J; Xie S; Weng J; Li X
ACS Appl Mater Interfaces; 2021 Dec; 13(49):58411-58421. PubMed ID: 34846117
[TBL] [Abstract][Full Text] [Related]
17. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
18. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.
Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y
J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532
[TBL] [Abstract][Full Text] [Related]
19. Progress of nanomaterials in the treatment of thrombus.
Shen Y; Yu Y; Zhang X; Hu B; Wang N
Drug Deliv Transl Res; 2024 May; 14(5):1154-1172. PubMed ID: 38006448
[TBL] [Abstract][Full Text] [Related]
20. Thrombus-targeted nanoparticles for thrombin-triggered thrombolysis and local inflammatory microenvironment regulation.
Zhang H; Qu H; He Q; Gao L; Zhang H; Wang Y; Zhang Z; Hou L
J Control Release; 2021 Nov; 339():195-207. PubMed ID: 34214595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
